Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia

As chronic myeloid leukemia is rare in children, most data on imatinib mesylate therapy is derived from adult studies. We retrospectively evaluated pediatric (<14 years) patients with Ph+ chronic myeloid leukemia treated with imatinib mesylate, from January 2003 through June 2008. Of the 12 chron...

Full description

Saved in:
Bibliographic Details
Main Authors: Belgaumi, Asim F., Al-Shehri, Ali, Ayas, Mouhab, Al-Mahr, Mohammed, Al-Seraihy, Amel, Al-Ahmari, Ali, El-Solh, Hassan
Format: Artigo
Language:Inglês
Published: Ferrata Storti Foundation 2010
Subjects:
Brief Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895048/
https://ncbi.nlm.nih.gov/pubmed/20410182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.015180
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items